Search results for "Protozoa"

showing 10 items of 222 documents

Selective permeabilization of infected host cells with pore-forming proteins provides a novel tool to study protein synthesis and viability of the in…

2001

Cell Membrane PermeabilityErythrocytesPlasmodium falciparumProtozoan ProteinsRicinPore forming proteinMicrobiologychemistry.chemical_compoundBacterial ProteinsmedicineProtein biosynthesisAnimalsHumansMalaria FalciparumMolecular BiologybiologyMacrophagesToxoplasma gondiiPlasmodium falciparumbiology.organism_classificationmedicine.diseaseToxoplasmosisCell biologyRicinchemistryStreptolysinsParasitologyStreptolysinToxoplasmaToxoplasmosisIntracellularMolecular and Biochemical Parasitology
researchProduct

Protein sorting in Plasmodium falciparum-infected red blood cells permeabilized with the pore-forming protein streptolysin O

1996

Plasmodium falciparum is an intracellular parasite of human red blood cells (RBCs). Like many other intracellular parasites, P. falciparum resides and develops within a parasitophorous vacuole which is bound by a membrane that separates the host cell cytoplasm from the parasite surface. Some parasite proteins are secreted into the vacuolar space and others are secreted, by an as yet poorly defined pathway, into the RBC cytosol. The transport of proteins from the parasite has been followed mainly using morphological methods. In search of an experimental system that would allow (i) dissection of the individual steps involved in transport from the parasite surface into the RBC cytosol, and (ii…

Cell Membrane PermeabilityErythrocytesPlasmodium falciparumProtozoan ProteinsVacuoleBiologymedicine.disease_causeBiochemistryPore forming proteinAdenosine TriphosphateCytosolBacterial ProteinsProtein targetingSerinemedicineAnimalsHumansMolecular BiologyIntracellular parasiteErythrocyte Membranehemic and immune systemsIntracellular MembranesCell BiologyCell biologyTransport proteinCytosolBiochemistryStreptolysinsVacuolesHost cell cytoplasmIntracellularcirculatory and respiratory physiologyResearch ArticleSubcellular FractionsBiochemical Journal
researchProduct

Ensemble-based ADME-Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE

2018

Abstract: In an effort to identify novel molecular warheads able to inhibit Leishmania mexicana cysteine protease CPB2.8CTE, fused benzo[b]thiophenes and ,'-triketones emerged as covalent inhibitors binding the active site cysteine residue. Enzymatic screening showed a moderate-to-excellent activity (12%-90% inhibition of the target enzyme at 20m). The most promising compounds were selected for further profiling including in vitro cell-based assays and docking studies. Computational data suggest that benzo[b]thiophenes act immediately as non-covalent inhibitors and then as irreversible covalent inhibitors, whereas a reversible covalent mechanism emerged for the 1,3,3'-triketones with a Y-to…

Cell SurvivalLeishmania mexicanaProtozoan ProteinsADME-Tox; Benzo[b]thiophenes; Cysteine protease; Leishmaniasis; TriketonesThiophenesCysteine Proteinase Inhibitors010402 general chemistry01 natural sciencesBiochemistryLeishmania mexicanaCysteine Proteinase InhibitorsCell LineInhibitory Concentration 50Structure-Activity RelationshipCysteine ProteasesCatalytic DomainDrug DiscoveryHumansStructure–activity relationshipcysteine proteaseBinding siteADME-Tox; benzo[b]thiophenes; cysteine protease; leishmaniasis; triketones; Biochemistry; Molecular MedicineBiologyleishmaniasisPharmacologychemistry.chemical_classificationVirtual screeningBinding Sitesbiology010405 organic chemistryPharmacology. TherapyOrganic Chemistrytriketonesbiology.organism_classificationCysteine protease0104 chemical sciencesMolecular Docking SimulationChemistryEnzymeBiochemistrychemistryDocking (molecular)ADME-ToxMolecular Medicinebenzo[b]thiophenes
researchProduct

Triazolopyridyl ketones as a novel class of antileishmanial agents. DNA binding and BSA interaction

2014

A new series of triazolopyridyl pyridyl ketones has been synthetized by regioselective lithiation of the corresponding [1,2,3]triazolo[1,5-a]pyridine at 7 position followed by reaction with different electrophiles. The in vitro antileishmanial activity of these compounds was evaluated against Leishmaniainfantum, Leishmaniabraziliensis, Leishmaniaguyanensis and Leishmaniaamazonensis. Compounds 6 and 7 were found to be the most active leishmanicidal agents. Both of them showed activities at micromolar concentration against cultured promastigotes of Leishmania spp. (IC₅₀=99.8-26.8 μM), without cytotoxicity on J774 macrophage cells. These two compounds were also tested in vivo in a murine model…

Cell SurvivalPyridinesStereochemistryClinical BiochemistryAntiprotozoal AgentsPharmaceutical SciencePlasma protein bindingBinding CompetitiveBiochemistryCell LineMicechemistry.chemical_compoundIn vivoDrug DiscoveryAnimalsA-DNABovine serum albuminLeishmaniasisMolecular BiologyLeishmaniaQuenching (fluorescence)biologyOrganic ChemistrySerum Albumin BovineDNAKetonesTriazolesIn vitroDisease Models AnimalSpectrometry FluorescenceLiverchemistrybiology.proteinMolecular MedicineCattleTriazolopyridineSpleenDNAProtein BindingBioorganic & Medicinal Chemistry
researchProduct

Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection.

2003

Abstract In order to test various viability assays for Cryptosporidium parvum oocysts were used to infect HCT-8 cells in vitro or baby mice. Infected cells were either stained with fluorescent anti- Cryptosporidium -antibody or lysed and subjected to C. parvum- specific PCR after 48 h. Titrations with infective oocysts were performed and compared to oocysts disinfected with Neopredisan © for 2 h at varying concentrations. Caecal smears and histological sections from infected animals were examined in parallel. The number of foci of parasite development in vitro after immunofluorescent staining correlated well with the infection dose. PCR was less quantifiable and the results were not always …

Cell Survivalanimal diseasesFluorescent Antibody TechniqueImmunofluorescencePolymerase Chain ReactionMicrobiologyCell LineCresolsMiceparasitic diseasesmedicineParasite hostingAnimalsCell SizeInfectivityCryptosporidium parvumGeneral Veterinarymedicine.diagnostic_testbiologyDose-Response Relationship DrugOocystsCryptosporidiumGeneral MedicineDNA Protozoanbiology.organism_classificationVirologyIn vitroStainingFungicides IndustrialDisinfectionCryptosporidium parvumbiology.proteinParasitologyAntibodyVeterinary parasitology
researchProduct

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy.

2018

Background Chagas cardiomyopathy is a serious and common complication of Chagas disease. Methods Through bibliometric and Social Network Analysis, we examined patterns of research on Chagas cardiomyopathy, identifying the main countries, authors, research clusters, and topics addressed; and measuring the contribution of different countries. Results We found 1932 documents on Chagas cardiomyopathy in the MEDLINE database. The most common document type was ‘journal article’, accounting for 79.6% of the total (n = 1538), followed by ‘review’ (n = 217, 11.2%). The number of published records increased from 156 in 1980–1984 to 311 in 2010–2014. Only 2.5% were clinical trials. Brazil and the USA …

Chagas diseaseChagas Cardiomyopathymedicine.medical_specialtyBoliviaLatin AmericansMyocarditislcsh:Arctic medicine. Tropical medicinelcsh:RC955-962MEDLINE030231 tropical medicineMEDLINECardiology030204 cardiovascular system & hematologyBibliometricsResearch and Analysis MethodsGeographical locations03 medical and health sciences0302 clinical medicineMedicine and Health SciencesParasitic DiseasesMedicineHumansChagas DiseaseCooperative BehaviorProtozoan Infectionsbusiness.industryResearchlcsh:Public aspects of medicinePublic Health Environmental and Occupational HealthSocial Supportlcsh:RA1-1270ScientometricsSouth AmericaResearch Assessmentmedicine.diseaseTropical DiseasesResearch PersonnelClinical trialInfectious DiseasesClinical researchBibliometricsFamily medicineCitation AnalysisPeople and placesbusinessCardiomyopathiesBrazilResearch ArticleNeglected Tropical DiseasesPLoS Neglected Tropical Diseases
researchProduct

Computational identification of chemical compounds with potential anti-Chagas activity using a classification tree

2021

Chagas disease is endemic to 21 Latin American countries and is a great public health problem in that region. Current chemotherapy remains unsatisfactory; consequently the need to search for new drugs persists. Here we present a new approach to identify novel compounds with potential anti-chagasic action. A large dataset of 584 compounds, obtained from the Drugs for Neglected Diseases initiative, was selected to develop the computational model. Dragon software was used to calculate the molecular descriptors and WEKA software to obtain the classification tree. The best model shows accuracy greater than 93.4% for the training set; the tree was also validated using a 10-fold cross-validation p…

Chagas diseaseComputer scienceTrypanosoma cruziAntiprotozoal AgentsQuantitative Structure-Activity RelationshipBioengineeringLigandsMachine learningcomputer.software_genre01 natural sciencesConstant false alarm rateSoftwareMolecular descriptorDrug DiscoveryChagas Diseaseclassification treeVirtual screeningMolecular Structure010405 organic chemistrybusiness.industryDecision tree learningGeneral Medicinevirtual screening0104 chemical sciences010404 medicinal & biomolecular chemistryIdentification (information)Tree (data structure)Anti-chagasic actionTest setMolecular MedicineArtificial intelligencebusinesscomputerSoftware
researchProduct

Chagas Disease Vector Control in a Hyperendemic Setting: The First 11 Years of Intervention in Cochabamba, Bolivia

2014

Background Chagas disease has historically been hyperendemic in the Bolivian Department of Cochabamba. In the early 2000s, an extensive vector control program was implemented; 1.34 million dwelling inspections were conducted to ascertain infestation (2000–2001/2003–2011), with blanket insecticide spraying in 2003–2005 and subsequent survey-spraying cycles targeting residual infestation foci. Here, we assess the effects of this program on dwelling infestation rates (DIRs). Methodology/Principal Findings Program records were used to calculate annual, municipality-level aggregate DIRs (39 municipalities); very high values in 2000–2001 (median: 0.77–0.69) dropped to ∼0.03 from 2004 on. A linear…

Chagas diseaseDisease EcologyBolivialcsh:Arctic medicine. Tropical medicineEndemic Diseaseslcsh:RC955-962EpidemiologyEctoparasitic Infestationsmedicine.disease_causeInsect ControlInfectious Disease EpidemiologyOddsInfestationTriatoma infestansparasitic diseasesmedicineMedicine and Health SciencesParasitic DiseasesAnimalsHumansChagas DiseasePublic and Occupational HealthTriatomaEctoparasitic infestationProtozoan InfectionsbiologyEcologylcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratiomedicine.diseasebiology.organism_classificationTropical DiseasesConfidence intervalInfectious DiseasesTriatomaEpidemiological MonitoringDemographyResearch ArticleNeglected Tropical DiseasesPLoS Neglected Tropical Diseases
researchProduct

Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.

2013

Chagas disease is today one of the most important neglected diseases for its upcoming expansion to non-endemic areas and has become a threat to blood recipients in many countries. In this study, the trypanocidal activity of ten derivatives of a family of aza-scorpiand like macrocycles is evaluated against Trypanosoma cruzi in vitro and in vivo murine model in which the acute and chronic phases of Chagas disease were analyzed. The compounds 4, 3 and 1 were found to be more active against the parasite and less toxic against Vero cells than the reference drug benznidazole, 4 being the most active compound, particularly in the chronic phase. While all these compounds showed a remarkable degree …

Chagas diseaseMacrocyclic CompoundsTrypanosoma cruziAntiprotozoal AgentsLigandsMicrobiologyMiceIn vivoDrug DiscoveryChlorocebus aethiopsmedicineEscherichia coliAnimalsHumansTrypanosoma cruziVero CellsCells CulturedPharmacologychemistry.chemical_classificationAza CompoundsMice Inbred BALB CbiologyMolecular StructureSuperoxide DismutaseOrganic ChemistryGeneral Medicinebiology.organism_classificationmedicine.diseaseIn vitroDisease Models AnimalEnzymechemistryMechanism of actionBenznidazoleImmunologyChronic DiseaseVero cellFemalemedicine.symptommedicine.drugEuropean journal of medicinal chemistry
researchProduct

Cissampeloflavone, a chalcone-flavone dimer from Cissampelos pareira

2003

From the aerial parts of Cissampelos pareira L. (Menispermaceae), a chalcone-flavone dimer has been isolated which, mainly from NMR spectroscopic and MS data, was proved to be 2-(4-hydroxy-3-methoxyphenyl)-7-(4-methoxyphenyl)-6-(2-hydroxy-4,6-dimethoxybenzoyl)-furano[3,2-g]benzopyran-4-one. This has been assigned the trivial name cissampeloflavone. The compound has good activity against Trypanosoma cruzi and T. brucei rhodesiense and has a low toxicity to the human KB cell line.

ChalconeMagnetic Resonance Spectroscopymedicine.drug_classStereochemistryDimerAntiprotozoal AgentsPlant ScienceHorticultureBiologyPharmacognosyBiochemistryFlavonesKB Cellschemistry.chemical_compoundChalconemedicineAnimalsHumansMenispermaceaeTrypanosoma cruziMolecular BiologyFlavonoidschemistry.chemical_classificationEukaryotaGeneral MedicineCissampelosPlant Components Aerialbiology.organism_classificationAntineoplastic Agents PhytogenicchemistryCissampelos pareiraAntiprotozoalDimerizationPhytochemistry
researchProduct